Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. - Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N (Oncotarget, 2017)